Citius Pharmaceuticals, Inc. CTXR Income Statement

Citius pharmaceuticals, inc. (CTXR)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10
Revenues
-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Expenses
Research and development
9,464	9,148	8,596	8,316	6,329	8,069	6,562	5,299	4,711	2,131	2,936	4,384	4,575	3,515	2,933	1,632	1,666	2,149	1,797	1,175	759	477	437	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
General and administrative
6,780	6,260	6,285	6,556	6,214	5,688	6,446	6,423	7,106	7,277	6,063	5,582	5,249	4,621	3,783	2,756	1,486	947	946	837	644	476	244	114	113	64	2	2	5	4	4	4	5	11	12	0	0	0
Stock-based compensation - general and administrative
720	765	715	729	649	660	779	807	949	1,035	986	1,022	1,036	852	732	622	505	498	486	851	687	578	470	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Professional Fees
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	25	15	15	13	15	12	12	7	13	0	0	0
Total Operating Expenses
16,964	16,173	15,598	15,602	13,193	14,418	13,789	12,530	12,767	10,444	9,986	10,990	10,861	8,989	7,449	5,011	3,658	3,595	3,229	2,864	2,091	1,532	1,152	565	567	526	28	17	20	18	19	17	18	18	25	0	0	0
Operating Loss
-16,964	-16,173	-15,598	-15,602	-13,193	-14,418	-13,789	-12,530	-12,767	-10,444	-9,986	-10,990	-10,861	-8,989	-7,449	-5,011	-3,658	-3,595	-3,229	-2,864	-2,091	-1,532	-1,152	-565	-567	-526	-28	-17	-20	-18	-19	-17	-18	-18	-25	0	0	0
Other Income (Expense)
Other income
0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest income
68	70	52	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on extinguishment of liability
-	-	-	-	-	-	-	-	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	3	3	2	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Gain on revaluation of derivative warrant liability
-	-	-	-	-	-	-	-	-	-	452	1,130	-221	-239	-838	-1,711	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain (loss) on revaluation of derivative warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense
16	16	16	16	15	16	15	796	825	840	850	71	42	22	8	4	0	0	7	26	60	100	128	0	0	0	-	-	-	-	-	-	1	1	0	0	0	0
Total Other Income, Net
162	164	36	843	818	1,253	1,252	-202	-366	-1,010	-398	1,059	-263	-261	-846	-1,603	-165	296	327	257	275	-28	-119	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Loss before Income Taxes
-	-	-	-	-	-	-	-	-	9,314	10,384	-9,931	-11,124	-9,250	-8,295	-6,614	-3,823	-3,299	-2,902	-2,606	-1,816	-1,561	-1,272	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	3	0	0	-	0	-	-	-	-	-	-
Loss before provision for income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-31	-21	-23	-20	-22	-19	-19	-19	-26	0	0	0
Income tax benefit
-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Loss
-16,802	-16,009	-15,562	-14,759	-12,375	-13,165	-12,536	-12,732	-13,133	-11,455	-10,384	-9,931	-11,124	-9,250	-8,295	-6,614	-3,823	-3,299	-2,902	-2,606	-1,816	-1,561	-1,272	-674	-644	-564	-31	-21	-23	-20	-22	-19	-19	-19	-26	0	0	0
Net Loss Per Share - Basic and Diluted
-0.13	-0.15	-0.15	-0.20	-0.20	-0.22	-0.16	-0.19	-0.44	-0.38	-0.42	-0.48	-0.55	-0.44	-1.15	-0.75	-0.35	-0.04	-1.30	-0.03	-0.01	-0.03	-0.56	0.00	-0.01	-0.03	-	-	-	-	-	-	-	-	-	-	-	-
Weighted Average Common Shares Outstanding
Basic and diluted
34,318	29,197	22,401	22,000	18,481	17,764	13,679	10,677	9,966	8,605	6,985	5,047	4,993	4,903	-27,249	4,844	2,482	34,414	-85,007	32,312	31,147	30,036	-31,735	17,843	17,757	17,757	-	-	-	-	-	-	-	-	-	-	-	-
Net income (loss) per share - basic (in Dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net income (loss) per share - diluted (in Dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Weighted average shares outstanding - basic (in Shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	18,000	18,000	18,000	18,000	18,000	18,000	18,000	18,000	18,000	18,000	18,000	18,000
Weighted average shares outstanding - diluted (in Shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	18,000	18,000	18,000	18,000	18,000	18,000	18,000	18,000	18,000	18,000	18,000	18,000